Cannabis use patterns in first episode psychosis and schizophrenia: A scoping review and case series.
Cannabis use is associated with psychosis development and symptom relapse in persons with schizophrenia spectrum disorders (SCZ). As U.S. states legalize can...
The association between major depressive disorder and cannabis use disorder: A meta-analysis and meta-regression analysis.
Major depressive disorder cannabis use is a critical area of study due to frequent co-occurrence. This meta-analysis examines prevalence estimates and clinical relevance. Understanding this association aids clinicians in patient care.
Cannabis Use Patterns in First Episode Psychosis and Schizophrenia: A Scoping Review and Case Series
Cannabis use patterns schizophrenia are critical to understanding psychosis and schizophrenia development. This review highlights inconsistent measurement methods in current research. Better assessment tools are needed for clinical practice in this…
Potential Effects of Cannabidiol on Formalin-Induced Inflammatory Pain in Morphine-Dependent Rats
This study investigates cannabidiol inflammatory pain effects in morphine-dependent rats using a formalin test model. Cannabidiol showed dose-dependent analgesic benefits in both acute and inflammatory pain phases. These findings suggest cannabidiol…
The association between major depressive disorder and cannabis use disorder: A meta-analysis and meta-regression analysis.
This meta-analysis on major depressive disorder cannabis use meta-analysis reveals significant prevalence of co-occurring conditions. It highlights the importance of integrated screening and treatment. Understanding this relationship is crucial for…